Results 121 to 130 of about 5,451,349 (285)
Safety and Efficacy of GLP‐1 Receptor Agonists in Adults With Epilepsy, Obesity, and Type 2 Diabetes
ABSTRACT Objective Managing obesity in patients with epilepsy is complicated by the weight‐gaining properties of essential antiseizure medications (ASMs) such as valproate and pregabalin. We evaluated the safety and efficacy of initiating glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) in this population.
Hyoshin Son +3 more
wiley +1 more source
Boletim Observatório América Latina - Ásia-Pacífico
No período janeiro-junho de 2013, o valor das exportações de bens da América Latina e Caribe para a Ásia-Pacífico chegou aos 102 bilhões de dólares, registrando um aumento de 5,1% em relação a igual período de 2012.
core +1 more source
Boundary‐Dependent Sleep–Wake Dysregulation in Idiopathic Hypersomnia
ABSTRACT Objective Idiopathic hypersomnia (IH) presents with excessive daytime sleepiness (EDS) despite apparently preserved nocturnal sleep, challenging traditional models of hypersomnolence based on sleep loss or fragmentation. We aimed to test the hypothesis that EDS in IH reflects excessive stabilization of the sleep state, consistent with ...
Samantha Mombelli +13 more
wiley +1 more source
Nerve anastomoses in the upper limb: an up-to-date meta-analysis. [PDF]
Plutecki D +9 more
europepmc +1 more source
El Reino Unido y América : inversiones e influencia económica [PDF]
Fundación MAPFRE América
core
Association Between Neurofilament Light Chain and Real‐World Ambulatory Function in Progressive MS
ABSTRACT Objective Neurofilament light chain (NfL) is a biomarker of neuroaxonal injury in multiple sclerosis (MS), yet associations with functional outcomes remain unclear. Longitudinal associations between serum NfL (sNfL) and daily step count (STEPS) from wearable devices were assessed in a large international progressive MS cohort.
Gabby B. Joseph +5 more
wiley +1 more source
Prevalence of overweight and obesity and the burden of high body-mass index in Latin America: a systematic analysis for the Global Burden of Disease Study 2023. [PDF]
Arrieta A +10 more
europepmc +1 more source

